{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:14:35Z","timestamp":1761948875140,"version":"3.37.3"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T00:00:00Z","timestamp":1690243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00417-023-06185-z","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T10:01:51Z","timestamp":1690279311000},"page":"3193-3200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Primary hyperaldosteronism in Acute Central Serous Chorioretinopathy: a real need for screening?"],"prefix":"10.1007","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6166-114X","authenticated-orcid":false,"given":"A.","family":"Valverde-Meg\u00edas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Montol\u00edo-Marzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Runkle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. I.","family":"Fern\u00e1ndez-Vigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,25]]},"reference":[{"key":"6185_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","volume":"33","author":"CMG Cheung","year":"2018","unstructured":"Cheung CMG, Lee WK, Koizumi et al (2018) Pachychoroid disease. Eye (Lond) 33:14\u201333","journal-title":"Eye (Lond)"},{"key":"6185_CR2","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","volume":"86","author":"M Wang","year":"2008","unstructured":"Wang M, Munch IC, Hasler et al (2008) Central serous chorioretinopathy. Acta Ophthalmol 86:126\u2013145","journal-title":"Acta Ophthalmol"},{"key":"6185_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","volume":"115","author":"AS Kitzmann","year":"2008","unstructured":"Kitzmann AS, Pulido JS, Diehl et al (2008) The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980\u20132002. Ophthalmology 115:169\u2013173","journal-title":"Ophthalmology"},{"key":"6185_CR4","doi-asserted-by":"publisher","first-page":"e66858","DOI":"10.1371\/journal.pone.0066858","volume":"8","author":"DC Tsai","year":"2013","unstructured":"Tsai DC, Chen SJ, Huang CC, Chou P et al (2013) Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001\u20132006: a population-based study. PLoS One 8:e66858. https:\/\/doi.org\/10.1371\/journal.pone.0066858","journal-title":"PLoS One"},{"key":"6185_CR5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2018.12.048","volume":"126","author":"S Mrejen","year":"2019","unstructured":"Mrejen S, Balaratnasingam C, Kaden TR et al (2019) Long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy. Ophthalmology 126:576\u2013588. https:\/\/doi.org\/10.1016\/j.ophtha.2018.12.048","journal-title":"Ophthalmology"},{"key":"6185_CR6","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1172\/JCI61427","volume":"122","author":"M Zhao","year":"2012","unstructured":"Zhao M, C\u00e9l\u00e9rier I, Bousquet E et al (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Investig 122:2672\u20132679. https:\/\/doi.org\/10.1172\/JCI61427","journal-title":"J Clin Investig"},{"key":"6185_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.oret.2018.09.003","volume":"3","author":"SK Wang","year":"2019","unstructured":"Wang SK, Sun P, Tandias RM, Seto BK, Arroyo JG (2019) Mineralocorticoid Receptor Antagonists in Central Serous Chorioretinopathy: A Meta-Analysis of Randomized Controlled Trials. Ophthalmol Retina 3:154\u2013160. https:\/\/doi.org\/10.1016\/j.oret.2018.09.003","journal-title":"Ophthalmol Retina"},{"key":"6185_CR8","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(19)32981-2","volume":"395","author":"A Lotery","year":"2020","unstructured":"Lotery A, Sivaprasad S, O\u2019Connell A et al (2020) Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial. Lancet 395:294\u2013303. https:\/\/doi.org\/10.1016\/S0140-6736(19)32981-2","journal-title":"Lancet"},{"key":"6185_CR9","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1007\/s00417-016-3417-8","volume":"254","author":"EHC van Dijk","year":"2016","unstructured":"van Dijk EHC, Nijhoff MF, Jong EK et al (2016) Central serous chorioretinopathy in primary hyperaldosteronism. Graefes Arch Clin Exp Ophthalmol 254:2033\u20132042. https:\/\/doi.org\/10.1007\/s00417-016-3417-8","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"6185_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11906-019-1001-4","volume":"21","author":"TM Seccia","year":"2019","unstructured":"Seccia TM, Caroccia B, Maiolino G, Cesari M, Rossi GP (2019) Arterial hypertension, aldosterone, and atrial fibrillation. Curr Hypertens Rep 21:94","journal-title":"Curr Hypertens Rep"},{"key":"6185_CR11","doi-asserted-by":"publisher","unstructured":"- Whelton P, Carey RM, Aronow WS, et al., (2018) ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am College Cardiol. E127-e248. https:\/\/doi.org\/10.1016\/j.jacc.2017.11.006","DOI":"10.1016\/j.jacc.2017.11.006"},{"key":"6185_CR12","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1161\/01.HYP.37.6.1440","volume":"37","author":"M Agharazii","year":"2001","unstructured":"Agharazii M, Douville P, Grose JH, Lebel M (2001) Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 37:1440\u20131443","journal-title":"Hypertension"},{"key":"6185_CR13","doi-asserted-by":"publisher","first-page":"147032031987089","DOI":"10.1177\/1470320319870891","volume":"20","author":"S Kidoguchi","year":"2019","unstructured":"Kidoguchi S, Sugano N, Hayashi-Ishikawa N et al (2019) The characteristics of captopril challenge test-positive patients using various criteria. J Renin Angiotensin Aldosterone Syst 20:1470320319870891. https:\/\/doi.org\/10.1177\/1470320319870891","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"6185_CR14","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"Mulatero P, Monticone S, Bertello C et al (2013) Long-term cardio and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab 98:4826\u20134833. https:\/\/doi.org\/10.1210\/jc.2013-2805","journal-title":"J Clin Endocrinol Metab"},{"key":"6185_CR15","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F et al (2016) The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 101:1889\u20131916","journal-title":"J Clin Endocrinol Metab"},{"key":"6185_CR16","doi-asserted-by":"publisher","unstructured":"-Ruiz-S\u00e1nchez JG, Pazos Guerra M, Meneses D, Runkle I. (2022) Primary hyperaldosteronism: when to suspect it and how to confirm its diagnosis. Endocrines 29\u201342. https:\/\/doi.org\/10.3390\/endocrines3010003","DOI":"10.3390\/endocrines3010003"},{"key":"6185_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11906-019-1001-4","volume":"21","author":"TM Seccia","year":"2019","unstructured":"Seccia TM, Caroccia B, Maiolino G et al (2019) Arterial hypertension, aldosterone, and atrial fibrillation. Curr Hypertens Rep 21:94","journal-title":"Curr Hypertens Rep"},{"key":"6185_CR18","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1055\/s-0043-121706","volume":"49","author":"MS Velema","year":"2017","unstructured":"Velema MS, de Nooijer AH, Burgers VWG et al (2017) Health-related quality of life and mental health in primary aldosteronism: a systematic review. Horm Metab Res 49:943\u2013950","journal-title":"Horm Metab Res"},{"key":"6185_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ajo.2016.02.012","volume":"165","author":"E Bousquet","year":"2016","unstructured":"Bousquet E, Dhundass M, Lehmann M et al (2016) Shift work: a risk factor for central serous chorioretinopathy. Am J Ophthalmol 165:23\u201328. https:\/\/doi.org\/10.1016\/j.ajo.2016.02.012","journal-title":"Am J Ophthalmol"},{"key":"6185_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/00006982-198700720-00009","volume":"7","author":"LA Yannuzzi","year":"1987","unstructured":"Yannuzzi LA (1987) Type-A behavior and central serous chorioretinopathy. Retina 7:111\u2013131","journal-title":"Retina"},{"key":"6185_CR21","doi-asserted-by":"publisher","unstructured":"-Ji Y, Li M, Zhang X, Peng Y, Wen F (2018) Poor sleep quality is the risk factor for central serous chorioretinopathy. J Ophthalmol 9450297. 2018. https:\/\/doi.org\/10.1155\/2018\/9450297","DOI":"10.1155\/2018\/9450297"},{"key":"6185_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich A, Matet A, Dirani A et al (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82\u2013118. https:\/\/doi.org\/10.1016\/j.preteyeres.2015.05.003","journal-title":"Prog Retin Eye Res"},{"key":"6185_CR23","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(87)91421-8","volume":"2","author":"JP Kahn","year":"1987","unstructured":"Kahn JP, Perumal AS, Gully RJ et al (1987) Correlation of type A behaviour with adrenergic receptor density: implications for coronary artery disease pathogenesis. Lancet 2:937\u2013939","journal-title":"Lancet"},{"key":"6185_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/jcm10030405","volume":"10","author":"Y Hirano","year":"2021","unstructured":"Hirano Y, Suzuki N, Tomiyasu T et al (2021) Multimodal Imaging of Microvascular Abnormalities in Retinal Vein Occlusion. J Clin Med 10:405. https:\/\/doi.org\/10.3390\/jcm10030405","journal-title":"J Clin Med"},{"key":"6185_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1161\/HYPERTENSIONAHA.117.10437","volume":"71","author":"SK Kim","year":"2018","unstructured":"Kim SK, McCurley AT, DuPont JJ et al (2018) Smooth Muscle Cell-Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging. Hypertension 71:609\u2013621. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.117.10437","journal-title":"Hypertension"},{"key":"6185_CR26","doi-asserted-by":"publisher","first-page":"e0242090","DOI":"10.1371\/journal.pone.0242090","volume":"15","author":"Y Ohshima","year":"2020","unstructured":"Ohshima Y, Higashide T, Sakaguchi K et al (2020) The association of primary aldosteronism with glaucoma-related fundus abnormalities. PLoS One 15:e0242090. https:\/\/doi.org\/10.1371\/journal.pone.0242090","journal-title":"PLoS One"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-023-06185-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-023-06185-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-023-06185-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T09:06:44Z","timestamp":1697706404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-023-06185-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,25]]},"references-count":26,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["6185"],"URL":"https:\/\/doi.org\/10.1007\/s00417-023-06185-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"type":"print","value":"0721-832X"},{"type":"electronic","value":"1435-702X"}],"subject":[],"published":{"date-parts":[[2023,7,25]]},"assertion":[{"value":"5 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of Hospital Cl\u00ednico San Carlos Ethics Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Hospital Cl\u00ednico San Carlos Ethics Committee approved this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers\u2019 bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}